Which glioblastoma patients will respond to immunotherapy?
Scientists have discovered a new biomarker to identify which patients with brain tumors called glioblastomas -- the most common and malignant of primary brain tumors -- might benefit from immunotherapy. The treatment could extend survival for an esti.....»»
Two previously unknown bacterial species identified from patients with inflammatory bowel disease
Investigators at University Medical Center Utrecht (the Netherlands) and Yale University (USA) have isolated and characterized two new bacterial species from patients with inflammatory bowel disease (IBD). The previously unknown bacterial species, wh.....»»
iPhone 15 Pro won’t feature clicky volume and power buttons
Apple analyst Ming-Chi Kuo is doubling down on his prediction that the iPhone 15 Pro models will switch from physical volume and power buttons to new solid-state buttons. If iPhone users “respond well” to this change, Kuo explains that Apple wil.....»»
Deciphering disease progression and cell processes with TIGER, in vivo and non-invasively
Could patients in the future simply ingest a diagnostic probiotic based on programmed ribonucleic acids to analyze their intestinal health from individual cells? Researchers at the Helmholtz Institute for RNA-based Infection Research (HIRI) and the J.....»»
Cells found to possess two mechanisms that allow them to respond to different force ranges
A study carried out at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) heralds a paradigm change in the field of mechanobiology. The study reveals that cells respond to forces of differing strength using use two distinct mechanisms, on.....»»
Security teams expect breach and incident reporting requirements to create more work
Most IT security professionals will focus on improving “detect” and “respond” capabilities, amidst concern over increasing costs and regulatory pressures, according to Deepwatch. The report found that digital transformation initiatives and re.....»»
Could getting rid of old cells turn back the clock on aging?
Researchers are investigating medicines that selectively kill decrepit cells. Enlarge (credit: Andrew Brookes/Getty Images) James Kirkland started his career in 1982 as a geriatrician, treating aging patients. But he fou.....»»
Here’s What’s Next for Pig Organ Transplants
2022 was a breakthrough year for xenotransplantation, a procedure that could be a lifeline for patients in desperate need of a donor......»»
Doc raked in $3.3M in wild spinal surgery scam, gets 5 years in prison
Patients left in "mental anguish" wondering "whether they needed a surgery." Enlarge / Surgeons performing a spinal surgery in Nice, France. (credit: Getty | BSIP) A federal judge in California has sentenced a neurosurge.....»»
People respond more intuitively to spoken language and more analytically when reading, study finds
Opinion poll or survey results could potentially change depending on whether respondents are provided with spoken or written information, new research suggests......»»
How Australian services can better respond to domestic, family and sexual violence
New research reports launched today from Australia's National Research Organisation for Women's Safety (ANROWS) capture the perspectives of people with lived experience and expertise on responses to domestic, family and sexual violence in Australia......»»
EV battery makers face emissions scrutiny, Panasonic unit chief says
Electric vehicles battery makers will need to respond to climate change and sustainability goals by disclosing their carbon footprints and reducing the use of rare metals, according to a senior executive at Panasonic's battery unit......»»
3D printing can help produce valuable radiopharmaceuticals
Without accurate diagnostics, it is difficult to talk about effective treatment of patients, especially in the case of cancer. Today, as much as 80% of diagnostic procedures using radiopharmaceuticals require the use of molybdenum-99. In the future,.....»»
NAVEX One COI Disclosures addresses conflicts of interest outside of annual campaigns
NAVEX launches NAVEX One COI Disclosures, enabling organizations to receive and address conflicts of interest (COI) matters outside of annual campaigns, empowering them to respond to ongoing disclosures and risks as they happen. Many organizations co.....»»
Viral surface-inspired nanocarriers for improved oral insulin therapy
Clinically, type 1 diabetes (T1DM) and advanced type 2 diabetes (T2DM) patients require multiple daily insulin injections to maintain blood glucose levels, which may cause great pain and is an inconvenience to patients and can lead to hyperinsulinemi.....»»
Prescription poop is here: FDA approves fecal slurry for unshakeable diarrhea
It's a win for those with C. diff and a milestone for microbiome-based therapies. Enlarge / Laboratory technicians in France prepare stool to treat patients with serious colon infections by fecal microbiota transplantation (FMT),.....»»
One step closer to tackling drug resistant parasites in Brazil
Researchers at the University of York are a step closer to identifying ways to support clinicians in predicting drug treatment outcomes for patients with visceral leishmaniasis in Brazil......»»
Novel nanoparticles deliver innovative cancer chemoimmunotherapy
University of Pittsburgh researchers have designed cancer-fighting nanoparticles that co-deliver a chemotherapy drug and a novel immunotherapy, according to a new Nature Nanotechnology study published today......»»
Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical
Cordio Medical, a medtech company based in Israel, has developed HearO, an app that can assist in monitoring congestive heart failure. The technology is based on the phenomenon whereby congestive heart failure patients demonstrate changes in their vo.....»»
Hackers sink to new low by stealing Discord accounts in ransomware attacks
AXLocker is a new ransomware attack that not only encrypts your files -- it also attempts to steal your Discord account, giving you 48 hours to respond......»»
For Alzheimer’s Scientists, the Amyloid Debate Has No Easy Answers
For years, potential therapies that attack this brain protein have failed to help patients in clinical trials. Now—surprisingly—a new drug shows promise......»»